Brand name: Berinert IV TM
Active ingredients: c1 esterase inhibitor
What it is used for
BERINERT IV is indicated for the treatment of acute attacks in patients with hereditary angioedema (HAE).
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White powder
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection, diluent for
Clear, colourless fluid
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store below 25 degrees Celsius
- Do not Freeze
- Protect from Light
- Shelf lifetime is 36 Months.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems